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Fibromyalgia is a major public health problem aﬀecting an estimated 200 to 400 million people worldwide. The purpose of
this study was to use the meta-analytic approach to determine the eﬃcacy and eﬀectiveness of randomized controlled exercise
intervention trials (aerobic, strength training, or both) on tender points (TPs) in adults with ﬁbromyalgia. Using random eﬀects
models and 95% conﬁdence intervals (CI), a statistically signiﬁcant reduction in TPs was observed based on per-protocol analyses
(8studiesrepresenting322participants)butnotintention-to-treatanalyses(5studiesrepresenting338participants)(per-protocol,
g, −0.68, 95% CI, −1.16, −0.20; intention-to-treat, g, −0.24, 95% CI, −0.62, 0.15). Changes were equivalent to relative reductions
of 10.9% and 6.9%, respectively, for per-protocol and intention-to-treat analyses. It was concluded that exercise is eﬃcacious for
reducing TPs in women with FM. However, a need exists for additional well-designed and reported studies on this topic.
1.Introduction
Fibromyalgia (FM), a chronic disorder characterized by
widespread musculoskeletal pain, fatigue, and tenderness
in localized areas, is a syndrome of unknown etiology. An
estimated 200 to 400 million adults worldwide have FM with
prevalence rates higher among women than men [1]. In
additiontothepersonalconsequences,substantialhealthcare
costs are accrued. For example, between 2002 and 2005, an-
nual healthcare costs in the US were three times higher in
people with FM versus those without FM [2].
Management of FM includes both pharmacologic and
nonpharmacologic approaches [3]. One nonpharmacologic
approach is exercise, a low-cost intervention that is available
to the vast majority of people with FM. A previous meta-
analysisthatincludedsixstudiespublisheduptoJulyof2005,
and in which one of the outcomes for widespread pain and
tenderness was tender-points (TP) assessment, concluded
that moderate-intensity aerobic exercise training probably
leads to little or no diﬀerence in TP scores while strength
trainingmayresultinlargereductionsinTPscores[4].How-
ever, since that time, additional studies leading to conﬂicting
results on this topic have been published and/or located
[5–8]. In addition, while the authors preferentially analyzed
intention-to-treatresults,theyalsomixedtheseanalyseswith
per-protocol results if data for the former were not available.
This may be problematic, since each approach attempts to
answer a diﬀerent research question [9]. Furthermore, meta-
analyses need to be updated on a regular basis [10]. Thus,
the purpose of this study was to use the meta-analytic ap-
proach to determine the eﬀects of exercise (aerobic, strength
training, or both) on chronic widespread pain and tender-
ness using TP scores in adults with FM.
2. Methods
2.1. Data Sources. Studies for the current meta-analysis were
retrieved from a large in-house exercise and rheumatic2 Arthritis
disease database that included 1024 citations after removing
duplicates. This database was developed by searching six
electronicsources(PubMed,EmBase,CochraneCentralReg-
ister of Controlled Clinical Trials, CINAHL, SPORTDiscus,
and Dissertation Abstracts Online), cross-referencing from
retrievedstudies,including reviewarticles,andexpertreview
(Dr. Miriam Nelson, Tufts University, personal communica-
tion, June 13, 2008). All computer searches were conducted
by the second author with the assistance of the ﬁrst author.
From the 1024 citations in the database, a search for studies
dealing with the eﬀects of exercise on widespread pain and
tenderness, as deﬁned by TP scores, in participants with
FM was conducted using the single keyword “ﬁbromyalgia”
while searching across all indexed ﬁelds within the database.
Detailed queries for original searches of each database are
available upon request from the corresponding author.
2.2.StudySelection. Theinclusioncriteriaforthisstudywere
(1) randomized controlled trials with the unit of assignment
at the participant level, (2) an exercise intervention group
(aerobic, strength training, or both), (3) exercise interven-
tions ≥4 weeks in duration, (4) a comparative control group
(nonintervention, usual care, and attention control), (5)
adults ages 18 years and older with FM as deﬁned by the
American College of Rheumatology [11], (6) published and
unpublished studies (master’s theses and dissertations), (7)
studies published in any language between January 1, 1980
and January 1, 2008, and (8) data available for TP scores
[4]. All methods of assessing TP were included because they
have been shown to correlate well with each other [12]. In
addition, while provisional criteria from the American Col-
lege of Rheumatology recently recommended that TP assess-
ment be replaced with a combination of a wide pain index
(WPI) and severity scale of symptoms (SS) score in the di-
agnosis of FM [13], past studies have relied primarily on
TP versus WPI and SS outcomes. Furthermore, these new
criteria are provisional in nature and have been criticized for
replacing TP assessment in the diagnosis of FM [14].
2.3. Data Abstraction. Codebooks for the abstraction of data
were developed and included the following major categories:
(1) study characteristics, (2) participant characteristics,
(3) exercise intervention characteristics, (4) TP assessment
characteristics, and (5) TP outcomes. All studies were coded
by the ﬁrst two authors, independent of each other. The au-
thors then reviewed every item for correctness. Disagree-
ments were resolved by consensus. Using Cohen’s kappa sta-
tistic [15], the overall agreement rate prior to correcting dis-
crepant items was 0.93, considered to be “almost perfect”
[16].
2.4. Risk of Bias Assessment. The risk of bias assessment tool
recently recommended by the Cochrane Collaboration was
used to assess bias across six domains: (1) sequence genera-
tion, (2) allocation concealment, (3) blinding to group as-
signment, (4) incomplete outcome data, (5) selective out-
come reporting, and (6) other potential bias [17]. Each
domain was classiﬁed as having either a high, low, or unclear
risk of bias [17]. The decision rule for blinding was that
participants, research personnel, and outcome assessors were
blinded to the primary outcome of interest, that is, changes
in TP. Blinding of all groups was considered important given
the subjective nature of TP measures. For other potential
sources of bias, we included baseline diﬀerences in TP be-
tween the exercise and control groups as well as whether all
subjects were reported as not participating in a regular exer-
cise program, as deﬁned by the authors, prior to taking part
in the study. All assessments were conducted by the ﬁrst two
authors, independent of each other. Both authors then met
and reviewed every item for agreement. Disagreements were
resolvedbyconsensus.UsingCohen’skappastatistic[15],the
overall interrater agreement prior to correcting discrepant
items was 0.62, considered to be “substantial” [16].
2.5. Statistical Analysis
2.5.1. Calculation of Study-Level Eﬀect-Size Estimates for TP.
The primary outcome of interest was changes in TP. Given
the diﬀerent metrics and reporting methods used, a stan-
dardized eﬀect size (g) was calculated for all TP outcomes
from each study [18]. This was accomplished by subtracting
the diﬀerence in change scores between the exercise and
control groups and then dividing by the pooled standard
deviation of the change scores [18]. All gs were adjusted for
small-sample bias [18]. To maintain independence, a pooled
g wascalculatedforallstudiesthatincludedmultipleexercise
groups and/or multiple TP measures, for example, tender
point count and myalgic score, while keeping per-protocol
and intention-to-treat results independent of each other. A
negative g was indicative of improvement in TP.
2.5.2. Pooled Estimates for TP. Random eﬀects models that
incorporate heterogeneity into the analysis were used to pool
TP outcomes (g) from each study and were reported accord-
ingtowhetherthedatawereanalyzedusingaper-protocolor
intention-to-treat approach. In terms of magnitude, values
for g of 0.20, 0.50, and 0.80 have been suggested to represent
small, medium, and large eﬀect sizes [19]. For g, two-tailed
95% conﬁdence intervals (CI) that did not include zero (0)
were considered to be statistically signiﬁcant. In order to de-
termine treatment eﬀects on the whole distribution, that is,
how treatment eﬀects from new individual trials would be
distributed about the mean, recently developed 95% predic-
tion intervals (PI) for meta-analysis were calculated for eﬀect
size changes in TP [20, 21].
Heterogeneity of TP outcomes between studies was ex-
amined using the Q statistic and a commonly used alpha
value for statistical signiﬁcance of 0.10 [18]. Consistency of
between-studyﬁndingsforTPoutcomeswereanalyzedusing
I2 [22]. Generally, I2 values of 25%, 50%, and 75% may be
consideredtorepresentsmall,medium,andlargeamountsof
inconsistency [22]. Small-study eﬀects were examined using
the regression approach of Egger et al. [23]. Small-study
eﬀects may be due to publication bias, selective reporting
of outcomes [24, 25], true heterogeneity [23, 26], artifacts
[27], or chance [28]. Two-tailed 95% conﬁdence intervalsArthritis 3
that did not include zero (0) were considered to be suggestive
ofsmall-study eﬀects.To examine theinﬂuenceofeachstudy
on the pooled results, each study was deleted from the model
once and the pooled analyses conducted with that one study
deleted from the model. Cumulative meta-analysis, ranked
by year, was also performed for the purpose of examining
changes in TP over time [29].
2.5.3. Moderator Analysis. Mixed eﬀects models were used
to examine potential between-group diﬀerences (Qb) when
partitioned according to type of training (aerobic, strength
training, or both), whether subjects were reported as seden-
tary prior to the intervention (yes versus unclear) and type
of analysis (per-protocol versus intention-to-treat). An alpha
level of ≤0.05 wasconsidered to be indicative of a statistically
signiﬁcant between-group (Qb)d i ﬀerence. Because of the
small number of studies included, as well as missing data for
diﬀerent variables from diﬀerent studies, we did not attempt
to conduct any additional moderator analyses.
2.5.4. Regression Analyses. Simple, mixed eﬀects meta-
regression (method of moments approach) was used to de-
termine the relationship between changes in TP and age in
years, symptom years, and weeks of exercise training accord-
ing to per-protocol and intention-to-treat analyses. Ninety-
ﬁve percent CIs that did not include zero (0) were considered
statistically signiﬁcant. Because of the small number of stud-
ies included, as well as missing data for diﬀerent variables
from diﬀerent studies, we did not attempt to conduct any
additional meta-regression analyses.
2.5.5. Other Analyses. Diﬀerences in baseline characteristics
(age,symptoms,anddiagnosis)wereanalyzedusingtheorig-
inal metric (years). These were calculated by subtracting the
baseline score in the exercise group from the baseline score
in the control group. Variances were calculated from the
pooled standard deviations of baseline scores in the exercise
and control groups. In addition, diﬀerences in dropout rates
between exercise and control groups were calculated using
the risk diﬀerence (RD). Random-eﬀects models were used
to pool results for all analyses, while heterogeneity and in-
consistency were examined using Q and I2,r e s p e c t i v e l y .
2.5.6. Data Reporting and Software. Data are reported as
mean with 95% CI, 95% PI, mean ± standard deviation (X±
SD) and median (Mdn) with interquartile range (IQR). All
data were analyzed using the metan routine [30] in Stata
(version 11.0) [31], Comprehensive Meta-Analysis (version
2.2) [32], and PASW (version 18.0) [33].
3. Results
3.1.StudyCharacteristics. Ofthe1,024studiesscreened,nine
representing 19 groups (10 exercise and 9 control) and 362
participants (200 exercise and 162 control) met the criteria
for inclusion [5–8, 34–38] .T h en u m b e ro fe x e r c i s eg r o u p s
exceeded the number of studies, because one study included
more than one exercise group [37]. A ﬂow diagram that
describes the search process is shown in Figure 1, while a
general description of the characteristics of each included
study is shown in Table 1. Two studies from a previous
systematic review [4] were excluded because they did not
meetallinclusioncriteria.Allofthestudieswerepublishedin
English-language journals between 1996 and 2007 [5–8, 34–
38]. Three studies were conducted in Canada [34, 36, 37],
two each in Finland [8, 35], and Spain [5, 7], and one
each in Norway [38] and the United States [6]. Five studies
reported using both per-protocol and intention-to-treat in
the analysis of their data [6, 34, 36–38] but per-protocol
data were not available for one of them [6]. Another three
studies were limited to the per-protocol approach [5, 7, 35],
while one reported no dropouts during the study [8]. All
studies used a repeated measures design [5–8, 34–38]. With
the exception of one study [8], all reported receiving funding
for conducting their project [5–7, 34–38]. Only two studies
included males [34, 38].
Results for risk of bias are shown in Figure 2.A c r o s s
all studies, the risk of bias for blinding was high, while the
risk for baseline diﬀerences in TP was low. For all studies,
it was unclear whether there was bias for selective reporting
of ﬁndings. With the exception of one study, the risk of bias
for sequence generation and incomplete outcome data was
considered low, while the risk of bias for allocation conceal-
ment was high. For one-third of the studies, the risk of bias
for participants not being sedentary prior to study entry was
unclear.
3.2. Participant Characteristics. A general description of the
participants for each group from each study is provided
in columns two through ﬁve of Table 1.T h en u m b e ro f
participants in the 10 exercise groups ranged from 8 to 30
(X ± SD = 20 ± 8; Mdn = 18, IQR = 17), while the number
of participants in the 9 control groups ranged from 10 to 31
(X ± SD = 18 ± 7; Mdn = 17, IQR = 10). The majority of
participants (98%) were female. The percentage of dropouts
ranged from 0% to 46.7% in the exercise groups (X ± SD
= 22.2% ± 18.9%; Mdn = 19%, IQR = 35%) and 0% to
63% in the control groups (X ± SD = 13.6% ± 21.4%; Mdn
= 0%, IQR = 2 2 % ) .At r e n df o rag r e a t e rp e r c e n t a g eo f
dropouts in the exercise versus control groups was found
(RD = 7.9%, 95% CI, −0.001, 0.16, Q = 16.7, p = 0.05, I2 =
46.2%, 95% CI, 0%, 74.2%). The mean between-group ages
of participants, in years, ranged from 39 to 60 in the exercise
groups and 37 to 59 in the controls. For those groups in
which data were available, the mean between-group number
of years reported for FM symptoms ranged from 7.8 to 24.0
in the exercise groups and from 7.0 to 19.0 in the controls,
while the mean between-group number of years reported for
the diagnosis of FM ranged from 2.8 to 7.6 in the exercise
groups and from 3.6 to 7.6 in the controls. No statistically
signiﬁcant diﬀerences were found between the exercise and
control groups in relation to baseline age, symptoms, or
diagnosis of FM (Table 2).
Five exercise and six control groups reportedly took
some type of prescribed drug for FM before and during
the intervention period. These included muscle relaxants,4 Arthritis
Records identiﬁed through original arthritis
database searches
(n = 1514)
- CINAHL (351) - EMBASE (111)
- Cochrane (451)
- DAI (1)
Records after duplicates removed
(n = 1024)
Records excluded, with reasons
(n = 128)
- All groups exercised (15)
- Abstract (2)
- Tender points not assessed (2)
Full-text articles assessed
for eligibility (n = 17)
- Tender points not assessed (4)
I
d
e
n
t
i
ﬁ
c
a
t
i
o
n
S
c
r
e
e
n
i
n
g
E
l
i
g
i
b
i
l
i
t
y
I
n
c
l
u
d
e
d
- PubMed (247)
- Some or all participants did not have
ﬁbromyalgia (6)
- Same participants as study already
included (2)
- Same participants as study already
included (3)
intervention (1)
Studies included in
quantitative synthesis
(meta-analysis)
(n = 9)
Full-text articles excluded, with reasons
(n = 8)
- SportDiscus (353)
Records screened from
arthritis database using
keyword “ﬁbromyalgia”
(n = 145) -S t u d y<4 weeks (3)
- Participants <18 years of age (2)
- Not an RCT exercise intervention (96)
- Not an RCT with exercise
Figure 1: Flow diagram for the selection of studies. Stepwise procedures used for the selection of tender point studies. Note that RCT means
randomized controlled trial.
antidepressants, anxiolytics, analgesics, nonsteroidal anti-
inﬂammatory drugs, hypnotics, anticonvulsants, and sleep
medications. For cigarette smoking, three groups (two exer-
cise and one control) reported including some participants
who smoked. Inadequate data were available for alcohol in-
take and diet.
Six exercise and ﬁve control groups were reported as
being sedentary prior to taking part in the study. For men-
opausal status, eight of the ten exercise groups and seven of
the nine control groups included both pre- and postmen-
opausal women, while one exercise and one control group
included pre- and postmenopausal women only. In relation
to overweight and obesity, 12 groups (six exercise and six
control) reported that one or more participants were over-
weight or obese.
3.3. Exercise Intervention Characteristics. A description of
the exercise interventions from each study are shown in
column 6 of Table 1. Five groups participated in aerobic
exercise, three in strength training, and two in both. For
the eight groups that reported data, six reported that the
exercise sessions were supervised, while two reported that
they were unsupervised. Length of training ranged from 12
to 23 weeks (X ± SD = 16 ± 4; Mdn = 16, IQR = 9), while
mean between-group frequency ranged from two to seven
sessions per week (X ± SD = 3 ± 1; Mdn = 3, IQR = 1). For
the four intervention groups in which adequate data were
available, mean between-group compliance, deﬁned as the
percentage of exercise sessions attended, ranged from 67%
to 97% (X ± SD = 83.2 ± 14.6; Mdn = 85, IQR = 27). For
those groups that participated in aerobic exercise, the mean
between-group duration of exercise in the four groups for
which adequate data were provided ranged from 12 to 25
minutes per session (X ± SD = 19 ± 5; Mdn = 20, IQR =
9). Within-group intensity of aerobic training ranged from
50% to 80% of maximum heart rate for the six groups inArthritis 5
Table 1: General characteristics of included studies.
Reference N Age (Years) Gender
(F/M)
FM symptoms
(Years) Exercise intervention Tender point
assessment
Gowans et al. [34] Ex: 27
Con: 23
Ex: 44.6 ± 8.7
Con: 49.8 ± 7.3
F (88%)/M
F (87%)/M
Ex: 9.6 ± 8.6
Con: 8.4 ± 7.6
23 weeks supervised,
facility-based aerobic exercise,
3x/wk, 20min/day, 60%–75%
MHR; compliance, 67%.
S u mo fu pt o1 8T P ;
assessor blinded to
group assignment
Gusi et al. [5] Ex: 17
Con: 17
Ex: 51 ± 10
Con: 51 ± 9
F
F
Ex: 24 ± 9
Con: 19 ± 8
12 weeks supervised
pool-based exercise, 3x/wk;
aerobic (20min/day,
65%–75% MHR,
strengthening (20min/day, 4
sets, 10reps); compliance
>94%
S u mo fu pt o1 8T P
Hakkinen et al. [35] Ex: 11
Con: 10
Ex: 39 ± 6
Con: 37 ± 5
F
F
Ex: 12 ± 4
Con: 12 ± 10
17 weeks supervised strength
training, 6–8ex, 2x/wk,
5–20reps, 40%–80% 1RM
S u mo fu pt o1 8T P
King et al. [36] Ex: 46
Con: 39
Ex: 45.2 ± 9.4
Con: 47.3 ± 7.3
F
F
Ex: 7.8 ± 6.1
Con: 9.6 ± 7.9
12 weeks supervised,
facility-based aerobic ex,
3x/wk, 10–40min/day, 75%
MHR
S u mo fu pt o1 8T P ;
both assessors blinded
to group assignment
Kingsley et al. [6] Ex: 15
Con: 14
Ex: 45 ± 9
Con: 47 ± 4
F
F
Ex: 9 ± 10
Con: 7 ± 5
12 weeks strength training,
11ex, 2x/wk, 1 set, 8–12reps,
40%–80% 1RM
Total number of TP
and total myalgic score;
assessor blinded to
group assignment
Mungu´ ıa-Izquierdo
and Legaz-Arrese [7]
Ex: 29
Con: 24
Ex: 50 ± 7
Con: 46 ± 8
F
F
Ex: 14 ± 10
Con: 14 ± 9
16 weeks supervised,
facility-based ex, 3x/wk;
strengthening (1–3 sets,
8–15reps, 8–10ex); aerobic
(20–30min, 50%–80%
MHR); compliance ≥75%
S u mo fu pt o1 8T P
Schachter et al. [37]
Ex (sb): 56
E x :( l b ) :5 1
Con: 36
Ex (sb): 41.9 ± 8.6
Ex: (lb): 41.3 ± 8.7
Con: 42.5 ± 6.7
F
F
F
Ex (sb): 8.6 ± 6.0
Ex (lb): 8.8 ± 6.2
Con: 8.8 ± 5.0
16 weeks home-based,
low-impact aerobic ex; short
bout, 2x/day, 3x/wk,
5–15min/session, 40%–75%
HRR; long bout, 1x/day,
3x/wk, 10–30min/session,
40%–75% HRR
Mean number of TP
and mean myalgic
score using a
dolorimeter; assessor
blinded to group
assignment
Valkeinen et al. [8] Ex: 13
Con: 13
Ex: 60 ± 2
Con: 59 ± 4
F
F NR
21 weeks supervised strength
training, 6–7ex, 2x/wk,
5–20reps, 40%–80% 1RM,
97% compliance
S u mo fu pt o1 8T P
Wigers et al. [38] Ex: 20
Con: 20
Ex: 43 ± 9
Con: 46 ± 9
F (90%)/M
F (95%)/M
Ex: 9.0 ± 5
Con: 11 ± 9
14 weeks supervised aerobic
exercise, 3x/wk,
18–20min/day, 60%–70%
MHR
Mean number of TP
using dolorimetry
Notes:Descriptionofgroupsandsubjectsfromeachstudylimitedtothosethatmettheinclusioncriteria; N,Initialnumberofsubjectsasreportedbyauthors;
a g er e p o r t e da sm e a n( X) ± standard deviation (SD); F, females; M, males; Ex, Exercise; Con, Control; FM, ﬁbromyalgia; MHR, maximum heart rate; 1RM,
one-repetitionmaximum;HRR,heartratereserve;lb,longbout;sb,shortbout;min,minutes;wk,week;reps,repetitions;TP,tenderpoints;NR,notreported.
Table 2: Baseline characteristics of exercise and control groups.
Exercise Control Diﬀerence Heterogeneity Inconsistency
Variable N X ±SD Mdn (IQR) N X ±SD Mdn (IQR) X (95% CI) Q (p) I2 (95% CI)
Age (years) 10 46.1 ± 6.1 45 (9) 9 47.3 ± 6.0 47 (6) −0.5 (−2.1, 1.0) 13.5 (0.14) 33.1% (0, 68.1)
FM Symptoms (years) 8 11.4 ± 5.1 9 (4) 8 11.2 ± 3.8 10 (5) 0.04 (−1.2, 1.2) 5.1 (0.65) 0% (0, 56.0%)
FM Diagnosis (years) 4 4.2 ± 2.3 3 (4) 3 5.1 ± 2.2 4 (4) −0.5 (−1.3, 0.3) 1.4 (0.71) 0% (0%, 72.0%)
Notes: FM, ﬁbromyalgia syndrome; N, number of groups reporting data; X ±SD, mean ± standard deviation; Mdn (IQR), median and interquartile range; X
(95% CI), mean and 95% conﬁdence intervals; Q (p), heterogeneity statistic and alpha value; I2 (95% CI), percent inconsistency and 95% conﬁdence interval.6 Arthritis
Subjects sedentary prior to entry
Selective reporting
Incomplete outcome data
Blinding
Allocation concealment
Sequence generation
100%
100%
100%
Low risk
High risk
Unclear
56%
11%
11%
11%
11% 33%
89%
89%
89%
Baseline values for TPs
Figure 2: Risk of bias assessment. Percentage of studies classiﬁed
as having a low, high, or unclear risk of bias for the seven listed
categories. Note that TP means tender points.
which data were available, while the duration of training
ranged from ﬁve to 40 minutes per session. Five of the seven
groups that participated in aerobic exercise included exercise
in the water, either alone or in conjunction with land-based
exercise. For the ﬁve groups that included strength training,
the within-group range was one to four sets (three groups
reporting), one to 20 repetitions (ﬁve groups reporting), six
to 11 exercises (four groups reporting), and 40% to 80% of
1-repetition maximum (three groups reporting).
3.4. TP Assessment Characteristics. A description of the
methods used for TP assessment is shown in the last column
of Table 1.T w o[ 6, 37] of the nine [5–8, 34–38] studies
included multiple measures for TP assessment, while three
reported using a dolorimeter [7, 37, 38]. Two studies in-
cludedamyalgicscore[7,37],andfourreportedthattheout-
come assessor was blinded to group assignment [6, 34, 36,
37].
3.5. TP Outcomes
3.5.1. Per-Protocol Analysis. Eight studies representing 322
participants (186 exercise and 146 control) were included in
the ﬁnal assessment of TP using the per-protocol approach
[5,7,8,34–38].Overall,astatisticallysigniﬁcantreductionin
TPwasfound(Table 3 andFigure 3).Thiswasequivalenttoa
relativereductionof10.9%.Astatisticallysigniﬁcantamount
of heterogeneity was observed as well as a large amount of
inconsistency. The 95% PI for a new trial was from −2.25
to 0.89. No statistically signiﬁcant small-study eﬀects were
observed(−5.1,95%CI, −15.1,4.9).Witheachstudydeleted
fromthemodelonce,resultsremainedstatisticallysigniﬁcant
across all deletions. Cumulative meta-analysis, ranked by
year, showed that TP results have remained statistically
signiﬁcant since 2005.
When a moderator analysis was conducted according
to type of training, statistically signiﬁcant reductions in
TP were limited to strength training with no within-group
heterogeneity (Table 3). Reductions in TP congruent with
strength training were equivalent to a relative reduction of
12.2%. However, no statistically signiﬁcant between-group
diﬀerences were observed for the three types of training
(Qb = 2.6, p = 0.28). For those studies in which participants
were reported as sedentary prior to enrollment, a statistically
signiﬁcant reduction of approximately 8.2% was found.
However, statistically signiﬁcant heterogeneity was observed
as well as a large amount of inconsistency. No statistically
signiﬁcant between-group diﬀerences were found (Qb =
0.004, p = 0.95). Meta-regression resulted in no statistically
signiﬁcant association between age (−0.02, 95% CI, −0.11,
0.05),symptomyears(0.01,95%CI, −0.09,0.12),andlength
of training (−0.03, 95% CI, −0.16, 0.10).
3.5.2. Intention-to-Treat Analysis. Five studies representing
338 participants (211 exercise, 127 control) were included in
pre- and post assessment of TP using the intention-to-treat
approach [6, 34, 36–38]. Overall, no statistically signiﬁcant
r e d u c t i o ni nT Pw a sf o u n d( Table 3 and Figure 4). This was
equivalent to a relative reduction of 6.9%. A statistically
signiﬁcant amount of heterogeneity was observed as well as a
moderate amount of inconsistency. When compared to per-
protocol results no statistically signiﬁcant between-group
differences were observed (Qb = 2.0, p = 0.16). The 95% PI
for a new trial was −1.48 to 1.0. No statistically signiﬁcant
small-study eﬀects were observed (−5.2, 95% CI, −14.4,
4.0). With each study deleted from the model once, results
remained nonsigniﬁcant across all deletions. Cumulative
meta-analysis, ranked by year, showed that results have been
nonsigniﬁcant since 2001. As can be seen in Table 3,n o
statistically signiﬁcant within or between-group diﬀerences
were found when intention-to-treat results were partitioned
according to type of training (Qb = 0.0, p = 0.99) or whether
participants were sedentary prior to enrollment (Qb =
0.22, p = 0.64). Meta-regression resulted in no statistically
signiﬁcant association between age (0.06, 95% CI, −0.25,
0.39),symptomyears(−0.39,95%CI, −0.96,0.17),orlength
of training (−0.01, 95% CI, −0.12, 0.09).
4. Discussion
The purpose of the current meta-analysis was to examine the
eﬀects of exercise on TP in adults with FM. The overall per-
protocol results, signiﬁcant since 2005 as well as with each
study deleted from the model once, suggest that exercise is
eﬃcacious for improving TP in selected women with FM. In
other words, potentially important beneﬁts can be derived
for those who comply with the exercise intervention [39].
However, it is not known whether the observed relative
reduction of 11% is practically important. Consequently,
other nonpharmacologic and/or pharmacologic interven-
tions may be necessary [40]. Regardless, exercise should
almost always be recommended because of the numerous
other beneﬁts that can be derived from such [41], including
those speciﬁc to adults with FM [42]. Along those lines, it
would appear prudent to recommend that women with FM
adhere to the general exercise guidelines recommended by
others [43–45].
While a signiﬁcant within-group reduction in TP for
strengthtrainingwasobserved,therewerenobetween-groupArthritis 7
Study name Statistics for each study Point estimate and 95% CI
Point
estimate
Lower
limit
Upper
limit
Gowans et al. (2001)
Gusi et al. (2006)
King et al. (2002)
Schachter et al. (2003)
Valkeinen et al. (2005)
Wigers et al. (1996)
−0.94
−0.66
−1.77
−0.43
−2.1
−0.85
−2.18
−2.21
−1.16
0.44
0.66
−0.03
0.72
−0.89
0.17
−0.52
−0.7
−0.2
−2.5 −1.25 0 1.25 2.5
Favors exercise Favors control
−0.25
0
−0.9
0.15
−1.49
−0.34
−1.35
−1.45
−0.68
Mungu´ ıa-Izquierdo et al. (2007)
Hakkinen et al. (2001)
Figure 3: Forest plot for changes in tender points according to per-protocol analysis. The black squares represent the standardized mean
diﬀerence (Hedge’s g), while the left and right extremes of the squares represent the corresponding 95% conﬁdence intervals. The middle
of the black diamond represents the overall standardized mean diﬀerence (Hedge’s g), while the left and right extremes of the diamond
represent the corresponding 95% conﬁdence intervals.
Table 3: TP results.
Variable Studies (#) g (95% CI) Q (p) I2 (95% CI)
PP Analysis
Overall 8 −0.68 (−1.16, −0.20)∗ 28.6 (<0.0001)∗∗ 75.5% (50.9%, 87.8%)
Type of training
Aerobic 4 −0.44 (−1.04, 0.16) 11.2 (0.01)∗∗ 73.2% (24.7%, 50.5%)
Strength 2 −1.13 (−1.73, −0.53)∗ 0.5 (0.47) 0%
Both 2 −0.75 (−2.22, 0.71) 10.8 (0.001)∗∗ 90.7% (66.7%, 97.4%)
Sedentary prior to enrollment
Yes 5 −0.67 (−1.23, −0.08)∗ 16.6 (0.002)∗∗ 76.0% (41.2%, 90.2%)
Unclear 3 −0.71 (−1.73, 0.31) 11.8 (0.003)∗∗ 83.1% (48.6%, 94.4%)
ITT Analysis
Overall 4 −0.24 (−0.62, 0.15) 10.1 (0.04)∗∗ 60.6% (0%, 85.2%)
Type of training
Aerobic 4 −0.24 (−0.71, 0.22) 10.1 (0.02)∗∗ 70.3% (37.4%, 93.7%)
Strength 1 0.25 (−0.96, 0.46) — —
Both — — — —
Sedentary prior to enrollment
Yes 2 −0.14 (−0.47, 0.20) 0.62 (0.43) 0%
Unclear 3 −0.33 (−1.1, 0.42) 9.4 (0.009)∗∗ 78.8% (32.2%, 93.4%)
Notes: PP, per-protocol; ITT, intention-to-treat; g (95% CI), Hedge’s g and 95% conﬁdence intervals; Q (p), heterogeneity statistic and alpha value; I2 (95%
CI), percent inconsistency and 95% conﬁdence interval; —, insuﬃcient data to calculate; ∗statistically signiﬁcant within-group diﬀerence because 95%
conﬁdence intervals do not include 0; ∗∗statistically signiﬁcant heterogeneity (p ≤ 0.10).
diﬀerences when compared to aerobic exercise or combined
aerobic and strength training. In addition, results for
strength training were based on only two outcomes. Fur-
thermore, given that studies are not randomly assigned to
predictors, moderator and meta-regression analyses are con-
sidered to be observational in nature [46]. Consequently,
such analyses do not support causal inferences [46]. Finally,
moderator and meta-regression analyses in aggregate data
m e t a - a n a l y s i st e n dt ob eu n d e r p o w e r e da sw e l la sb e i n gs u b -
jected to potential confounding and ecological bias [47].
Clearly, the validity of the current per-protocol ﬁndings
needs to be tested in large, well-designed randomized con-
trolled trials.
The lack of statistically signiﬁcant ﬁndings for intention-
to-treat analyses suggest that overall, exercise is not eﬀective
for reducing TP scores in women with FM. In other words,
when the results of participants who drop out of an exercise
intervention are pooled with those who do not drop out,
the overall positive eﬀect of exercise across all participants is
no longer signiﬁcant [39]. This has important implications8 Arthritis
Gowans et al. (2001) −0.31 −0.86 0.24
King et al. (2002) 0.21 −0.24 0.66
Kingsley et al. (2005) −0.25 −0.96 0.46
Schachter et al. (2003) −0.03 −0.45 0.39
Wigers et al. (1996) −1.02 −1.67 −0.38
−0.24 −0.62 0.15
Study name Statistics for each study Point estimate and 95% CI
Point
estimate
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limit
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−2 −1 012
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Figure 4:Forestplotforchangesintenderpointsaccordingtointention-to-treatanalysis.Theblacksquaresrepresentthestandardizedmean
diﬀerence (Hedge’s g), while the left and right extremes of the squares represent the corresponding 95% conﬁdence intervals. The middle
of the black diamond represents the overall standardized mean diﬀerence (Hedge’s g), while the left and right extremes of the diamond
represent the corresponding 95% conﬁdence intervals.
when recommending various interventions such as exercise
in the prevention and treatment of disease. However, the lack
ofstatisticallysigniﬁcantﬁndingsbasedonintention-to-treat
analysis may have been the result of a lack of statistical power
for the current meta-analysis. For example, post hoc power
analysis using previously developed methods for meta-
analysis[48]resultedinapo werof0.44forintention-to-treat
ﬁndings.
Future randomized controlled exercise intervention
studies in adults with FM could improve on the reporting of
several variables. Based on our risk of bias assessment, future
studies should make sure to report the protocol number
for their study so that one can determine whether selective
outcome reporting occurred. In addition, information on
whether the participants were sedentary prior to taking part
in the study is important since the eﬀects of exercise may
not be fully realized if the participants had been exercising
priortoenrollment.GiventhesubjectivenatureofTPassess-
ment, information on blinding of the participant, outcome
assessor, and other relevant personnel is also needed. How-
ever, the risk of bias for blinding may always be high given
thediﬃcultyinblindingparticipantstotheexerciseinterven-
tion. Future studies need to also do a better job in providing
complete information on the number of years since the
diagnosis of FM, diet intake, including alcohol, as well as any
therapies,pharmacologicornonpharmacologic,inwhichthe
participants are engaged. Finally, complete information on
the exercise interventions should be reported. For aerobic
exercise, this includes the length, frequency, intensity and
duration of exercise as well as the training modality, com-
pliance to the exercise protocol, equipment used, if any, and
setting in which exercise took place. For strength training,
this includes the length, frequency, intensity and duration of
exercise, number of sets, repetitions and exercises, rest pe-
riod between exercises, equipment used, if any, as well as
compliance to the exercise protocol and setting in which ex-
ercise took place.
Several suggestions regarding future studies appear ap-
propriate. For example, while the prevalence of FM is greater
in women than in men [49], it is recommended that future
studies include more men in randomized controlled exercise
intervention studies. This is especially true given that 98% of
the participants included in the current meta-analysis were
women. Given the current emphasis on dose response [50],
future randomized controlled trials should also include dif-
ferent exercise training regimens in order to determine the
optimal exercise program or programs for adults with FM.
The major strength of the current meta-analysis is the re-
porting of separate results according to per-protocol and
intention-to-treat analyses, thus allowing one to determine
whether the treatment works (per-protocol analysis) as well
as whether it works in the real world (intention-to-treat
analysis) [39]. While the results of the current meta-analysis
provide important, updated information in relation to
the eﬃcacy and eﬀectiveness of exercise on TP scores in
participants with FM, these ﬁndings need to be viewed with
respect to the following potential limitations beyond those
previously mentioned. First, a moderate-to-large amount of
heterogeneity and inconsistency was observed for our TP
results. Given these ﬁndings and despite the fact that a
random-eﬀects model that incorporates heterogeneity into
the analysis was used, the generalization of such results may
not be appropriate [17]. However, the use of such statistics
to determine true heterogeneity and inconsistency is rather
arbitrary in nature, and thus, should be viewed with caution
[51]. A second potential limitation is the fact that the predic-
tionintervalsforestimatingtheexpectedresultsofanewtrial
includedzeroforTPoutcomes.However,thesevaluesshould
not be confused with conﬁdence intervals since prediction
intervalsarebasedonarandommeaneﬀectwhileconﬁdence
intervals are not [20, 21]. A third potential limitation is
the large number of statistical tests that were conducted. As
a result, some of the signiﬁcant ﬁndings could have been
nothing more than chance ﬁndings. However, adjustmentsArthritis 9
for multiple tests were not made because of the more severe
problems associated with such [52, 53].
5. Conclusions
The results of the current meta-analysis suggest that exercise
is eﬃcacious for reducing TP scores in selected women with
FM. These ﬁndings are important, because they provide
support for the use of exercise for decreasing widespread
pain and tenderness in women who exercise on a regular
basis.However,aneedexistsforadditionalwell-designedand
reported studies on this topic, especially those that examine
the eﬀectiveness (intention-to-treat approach) of exercise on
TP scores in men and women with FM.
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